Literature DB >> 6626286

Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis.

J A Engelbrecht, S L Calhoon, J J Scherrer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6626286     DOI: 10.1002/art.1780261016

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  9 in total

Review 1.  Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.

Authors:  F Salaffi; P Manganelli; M Carotti; S Subiaco; G Lamanna; C Cervini
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

Review 2.  Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review.

Authors:  Federico Rondon; Odilio Mendez; Nestor Spinel; Carlos Ochoa; Cristian Saavedra; Edgar Penaranda; Ignacio Garcia-Valladares; Luis R Espinoza; Antonio Iglesias-Gamarra
Journal:  Clin Rheumatol       Date:  2011-05-26       Impact factor: 2.980

3.  Low dose methotrexate pneumonitis in rheumatoid arthritis.

Authors:  S Louie; G A Lillington
Journal:  Thorax       Date:  1986-09       Impact factor: 9.139

4.  Methotrexate therapy in rheumatoid arthritis. Current status.

Authors:  W S Wilke; A H Mackenzie
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 5.  Methotrexate-related pulmonary complications in rheumatoid arthritis.

Authors:  P Barrera; R F Laan; P L van Riel; P N Dekhuijzen; A M Boerbooms; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

Review 6.  Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature.

Authors:  M G Ridley; C S Wolfe; J A Mathews
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

Review 7.  A clinical and economic review of disease-modifying antirheumatic drugs.

Authors:  S E Gabriel; D Coyle; L W Moreland
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

8.  Sustained cough in methotrexate therapy for rheumatoid arthritis.

Authors:  A Schnabel; K Dalhoff; S Bauerfeind; J Barth; W L Gross
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

Review 9.  Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports.

Authors:  M R Hargreaves; A G Mowat; M K Benson
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.